What are the key presentations at EASL 2026 regarding pemvidutide
FDA-approved GLP-1 medications work by mimicking a natural hormone that enhances insulin secretion, suppresses glucagon, and slows gastric emptying
Aardvark Therapeutics ARD-101 Aardvarks lead candidate, oral ARD-101 , is a potent pan-agonist of bitter taste receptors (TAS2R) that stimulates enteroendocrine cells in the digestive tract, triggering the release of gut-peptide hormones like GLP-1 and cholecystokinin (CCK), a satiety hormone that activates gut-brain signaling to regulate hunger
However, some people may experience dizziness, lightheadedness, or injectionrelated discomfort, especially shortly after administration
Koyuturk M, Bolkent S, Ozdil S, Arbak S, Yanardag R
Our formulations are science-backed, non-GMO, allergen-free, and designed to support long-term health with clarity and integrity